286
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Maternal blood EBF1-based microRNA transcripts as biomarkers for detecting risk of spontaneous preterm birth: a nested case-control study

ORCID Icon, , , &
Pages 1239-1247 | Received 12 Nov 2019, Accepted 17 Mar 2020, Published online: 01 Apr 2020

References

  • Ananth CV, Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med. 2006;19(12):773–782.
  • Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
  • Saade GR, Boggess KA, Sullivan SA, et al. Development and validation of a spontaneous preterm delivery predictor in asymptomatic women. Am J Obstet Gynecol. 2016; 214(5):633.e1–633.e24.
  • Esplin MS, Elovitz MA, Iams JD, et al. Predictive accuracy of serial transvaginal cervical lengths and quantitative vaginal fetal fibronectin levels for spontaneous preterm birth among nulliparous women. JAMA. 2017;317(10):1047–1056.
  • Zhang G, Feenstra B, Bacelis J, et al. Genetic associations with gestational duration and spontaneous preterm birth. N Engl J Med. 2017;377(12):1156–1167.
  • Heng YJ, Pennell CE, McDonald SW, et al. Maternal whole blood gene expression at 18 and 28 weeks of gestation associated with spontaneous preterm birth in asymptomatic women. PLoS One. 2016;11(6):e0155191.
  • Zhou G, Holzman C, Heng YJ, et al. Maternal blood EBF1 gene expression and spontaneous preterm birth. Reprod Sci. 2020;27(1):316–324.
  • Bartel DP. MicroRNA target recognition and regulatory functions. Cell. 2009;136(2):215–233.
  • Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769–773.
  • Hashimoto Y, Akiyama Y, Yuasa Y. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One. 2013;8(5):e62589.
  • Rinck A, Preusse M, Laggerbauer B, et al. The human transcriptome is enriched for miRNA-binding sites located in cooperativity-permitting distance. RNA Biol. 2013;10(7):1125–1135.
  • Rouillard AD, Gundersen GW, Fernandez NF, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016:baw100.
  • Huang C, Xiao X, Chintagari NR, et al. MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome. BMC Med Genomics. 2014;7(1):46.
  • Taniguchi M, Nakajima I, Chikuni K, et al. MicroRNA-33b downregulates the differentiation and development of porcine preadipocytes. Mol Biol Rep. 2014;41(2):1081–1090.
  • Belarbi Y, Mejhert N, Gao H, et al. MicroRNAs-361-5p and miR-574-5p associate with human adipose morphology and regulate EBF1 expression in white adipose tissue. Mol Cell Endocrinol. 2018;472:50–56.
  • Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. PNAS. 2007;104(45):17719–17724.
  • Ramalingam P, Palanichamy JK, Singh A, et al. Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicing. RNA. 2014;20(1):76–87.
  • Dias RG, Silva MSM, Duarte NE, et al. PBMCs express a transcriptome signature predictor of oxygen uptake responsiveness to endurance exercise training in men. Physiol Genomics. 2015;47(2):13–23.
  • Gacic J, Vorkapic E, Olsen RS, et al. Imatinib reduces cholesterol uptake and matrix metalloproteinase activity in human THP-1 macrophages. Pharmacol Rep. 2016;68(1):1–6.
  • Place RF, Li LC, Pookot D, et al. MicroRNA-373 induces expression of genes with complementary promoter sequences. PNAS. 2008;105(5):1608–1613.
  • Zhou H, Rigoutsos I. MiR-103a-3p targets the 5’ UTR of GPRC5A in pancreatic cells. RNA. 2014;20(9):1431–1439.
  • Wongfieng W, Jumnainsong A, Chamgramol Y, et al. 5’ UTR and 3’-UTR regulation of MICB expression in human cancer cells by novel microRNAs. Genes. 2017;8(9):213.
  • Sulc M, Marin RM, Robins HS, et al. PACCMIT/PACCMIT-CDS: identifying microRNA targets in 3’ UTRs and coding sequences. Nucleic Acids Res. 2015;43(W1):W474–W479.
  • Liu G, Zhang R, Xu J, et al. Functional conservation of both CDS- and 3’-UTR-located microRNA binding sites between species. Mol Biol Evol. 2015;32(3):623–628.
  • Zhang K, Zhang X, Cai Z, et al. A novel class of microRNA-recognition elements that function only within open reading frames. Nat Struct Mol Biol. 2018;25(11):1019–1027.
  • Chipman LB, Pasquinelli AE. miRNA targeting: growing beyond the seed. Trends Genet. 2019;35(3):215–222.
  • Sticht C, De La Torre C, Parveen A, et al. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13(10):e0206239.
  • Dweep H, Sticht C, Pandey P, et al. miRWalk – database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Informatics. 2011;44(5):839–847.
  • Liu C, Mallick B, Long D, et al. CLIP-based prediction of mammalian microRNA binding sites. Nucleic Acids Res. 2013;41(14):e138–e138.
  • Rennie W, Kanoria S, Liu C, et al. STarMirDB: a database of microRNA binding sites. RNA Biol. 2016;13(6):554–560.
  • Law CW, Alhamdoosh M, Su S, et al. RNA-seq analysis is easy as 1-2-3 with limma. F1000Res. 2016;5:1408.
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47.
  • Griffin MJ, Zhou Y, Kang S, et al. Early B-cell factor-1 (EBF1) is a key regulator of metabolic and inflammatory signaling pathways in mature adipocytes. J Biol Chem. 2013;288(50):35925–35939.
  • Gyory I, Boller S, Nechanitzky R, et al. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev. 2012;26(7):668–682.
  • Prasad MA, Ungerbäck J, Åhsberg J, et al. Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency. Blood. 2015;125(26):4052–4059.
  • Georgopoulos K. Ebf1 in DNA repair and leukemogenesis. Blood. 2015;125(26):3969–3971.
  • Bishara AJ, Hittner JB. Confidence intervals for correlations when data are not normal. Behav Res. 2017;49(1):294–309.
  • Hu X, Jung A, Qin G. Interval estimation for the correlation coefficient. Am Stat. 2020;74(1):29–36.
  • Newson RB. Comparing the predictive power of survival models using Harrell’s c or Somers’ D. Stata J. 2010;10(3):339–358.
  • Ruopp MD, Perkins NJ, Whitcomb BW, et al. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50(3):419–430.
  • Luque-Fernandez MA, Maringe C, Nelson P. CVAUROC: stata module to compute cross-validated area under the curve for ROC analysis after predictive modelling for binary outcomes. 2017. https://scholar.harvard.edu/malf/publications/cvauroc-stata-module-compute-cross-validated-area-under-curve-roc-analysis-after.
  • Elovitz MA, Anton L, Bastek J, et al. Can microRNA profiling in maternal blood identify women at risk for preterm birth? Am J Obstet Gynecol. 2015;212(6):782.e1–5.
  • Gray C, McCowan LM, Patel R, et al. Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study. Sci Rep. 2017;7(1):815.
  • Winger EE, Reed JL, Ji X. Early first trimester peripheral blood cell microRNA predicts risk of preterm delivery in pregnant women: proof of concept. PLoS One. 2017;12(7):e0180124.
  • Wommack JC, Trzeciakowski JP, Miranda RC, et al. Micro RNA clusters in maternal plasma are associated with preterm birth and infant outcomes. PLoS One. 2018;13(6):e0199029.
  • Cook J, Bennett PR, Kim SH, et al. First trimester circulating microRNA biomarkers predictive of subsequent preterm delivery and cervical shortening. Sci Rep. 2019;9(1):5861.
  • Menon R, Debnath C, Lai A, et al. Circulating exosomal miRNA profile during term and preterm birth pregnancies: a longitudinal study. Endocrinol. 2019;160(2):249–275.
  • Krautenbacher N, Theis FJ, Fuchs C. Correcting classifiers for sample selection bias in two-phase case-control studies. Comput Math Methods Med. 2017;2017:1–18.
  • Wang L, Huang Y. Evaluating classification performance of biomarkers in two-phase case-control studies. Stat Med. 2019;38(1):100–114.
  • Sepúlveda-Martínez A, Rencoret G, Silva MC, et al. First trimester screening for preterm and term pre-eclampsia by maternal characteristics and biophysical markers in a low-risk population. J Obstet Gynaecol Res. 2019;45(1):104–112.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.